R&D, strategic alliances and shareholder value in biotech industry.
The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" v...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Theses and Dissertations |
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/7721 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Nanyang Technological University |
| Summary: | The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent
decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create
shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape
proposals for improved information disclosure on organizational capital. |
|---|